Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421735 | SCV000521759 | likely benign | not specified | 2015-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000869631 | SCV001011072 | likely benign | Long QT syndrome | 2023-05-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436268 | SCV002751525 | uncertain significance | Cardiovascular phenotype | 2019-09-20 | criteria provided, single submitter | clinical testing | The c.2961-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 23 in the CACNA1C gene. This nucleotide position is not well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor/donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |